Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Current Leases (2020 - 2024)

Lite Strategy (LITS) posted Current Leases of $1.1 million for Q1 2024, up 3.65% on a QoQ basis from $1.0 million in Q4 2023, and down 24.04% year-over-year from $1.4 million in Q2 2023.

Analysis

Lite Strategy (LITS) Current Leases (2020 - 2024) Analysis & Trends

Lite Strategy has reported Current Leases for 5 years, with the latest figure at $1.1 million in Q1 2024.

  • On a quarterly basis, Current Leases fell 24.04% year-over-year to $1.1 million in Q1 2024; TTM through Mar 2024 was $1.1 million, a 24.04% decrease from a year earlier, with the FY2023 full-year figure at $1.4 million, up 63.95% from the prior year.
  • Current Leases was $1.1 million for Q1 2024 at Lite Strategy, up from $1.0 million in the prior quarter.
  • The five-year high for Current Leases was $1.4 million in Q2 2023, with the low at $602000.0 in Q3 2020.
  • Average Current Leases over 5 years is $1.0 million, with a median of $987000.0 recorded in 2021.
  • The largest YoY upside for Current Leases was 67.27% in 2023 against a maximum downside of 24.42% in 2023.
  • Over 5 years, Current Leases stood at $873000.0 in 2020, then increased by 13.06% to $987000.0 in 2021, then surged by 36.07% to $1.3 million in 2022, then retreated by 24.42% to $1.0 million in 2023, then advanced by 3.65% to $1.1 million in 2024.
  • The last three Current Leases figures came in at $1.1 million (Q1 2024), $1.0 million (Q4 2023), and $1.1 million (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 11.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 12.38 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.05 Mn
Dec 31, 2023 1.02 Mn
Sep 30, 2023 1.06 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.39 Mn
Dec 31, 2022 1.34 Mn
Sep 30, 2022 1.30 Mn
Jun 30, 2022 871,000.00
Mar 31, 2022 828,000.00
Dec 31, 2021 987,000.00
Sep 30, 2021 957,000.00
Jun 30, 2021 928,000.00
Mar 31, 2021 900,000.00
Dec 31, 2020 873,000.00
Sep 30, 2020 602,000.00